Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺50.763,51, with a 24-hour trading volume of ₺68,84B. The asset's market cap is ₺45,26T, after moving -1.71% in the last day.
Tokenized Eli Lilly And Co is trading at ₺50.979,35, with a tokenized market cap of ₺1,99B and a 24-hour trading volume of ₺132,37M. The tokenized asset has moved -6.15% in the past 24 hours.